Form 4: QuidelOrtho Director Evelyn Dilsaver Acquires 482 Shares Through RSU Release

QuidelOrtho Corp Director Evelyn S. Dilsaver acquired 482 shares of common stock on May 24, 2025, through the release of restricted stock units as part of a deferred compensation program, increasing her total beneficial ownership to 10,624 shares.

Summary

• Evelyn S. Dilsaver, a Director of QuidelOrtho Corp (QDEL), acquired a total of 482 shares of common stock on May 24, 2025.
• The acquisition consisted of two separate releases of restricted stock units (RSUs): 402 shares and an additional 80 shares, both at a price of $0.
• These RSUs represent the right to receive one share of QuidelOrtho Corporation common stock for each unit.
• The release of these restricted stock units was deferred under QuidelOrtho's compensation program for non-employee directors, occurring according to a pre-elected deferred schedule.
• Following these transactions, Evelyn S. Dilsaver's direct beneficial ownership of QuidelOrtho common stock increased to 10,624 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine disclosure of a pre-scheduled compensation event (release of restricted stock units) for a director, with no discretionary purchase or sale activity that would indicate a specific sentiment towards the company's prospects.

Positives

• The transaction reflects the vesting and release of previously granted restricted stock units, indicating a routine compensation event for a non-employee director.
• The increase in direct beneficial ownership by a director aligns their interests further with shareholders.

Negatives

• The document does not contain any negative information; it is a standard disclosure of an insider transaction related to compensation.

Risks

• This SEC Form 4 filing does not contain information regarding company-specific risks or future challenges.

Future Outlook

This document, an SEC Form 4, is a disclosure of an insider transaction and does not provide any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This filing is a routine insider transaction disclosure and does not provide information relevant to broader industry trends or competitive analysis within the diagnostics or medical device sectors.

Corporate Governance

Related Party Transactions

• The transaction involves the acquisition of shares by a director (Evelyn S. Dilsaver) from the company (QuidelOrtho Corp) as part of a compensation program, which is a form of related party transaction inherent to insider compensation.

Stakeholder Impact

• Shareholders: The increase in a director's beneficial ownership aligns their interests more closely with shareholders, potentially signaling confidence in the company's long-term performance.
• Employees: No direct impact on employees is indicated by this filing.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

Keywords

QuidelOrtho Corp, QDEL, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Release, Director Compensation, Beneficial Ownership, Evelyn S. Dilsaver, Deferred Compensation